Rapport Therapeutics, Inc.
financial.report · SEC EDGAR
This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
financial.report
Occurred
2025-12-31
Reported
2026-03-10
Disclosure lag
69 days
Context
links are based on the recorded entity type| Field | Recorded value |
|---|---|
| Entity | Rapport Therapeutics, Inc. |
| Source | SEC EDGAR ↗ |
| Source identifier | companyfacts/CIK0002012593/2026-07-26 |
| Event ID | #51476 |
Recorded payload
JSON payload as stored after parsing{
"accession": "0001193125-26-099360",
"canonical_covered": 11,
"canonical_total": 12,
"fiscal_period": "FY",
"fiscal_year": 2025,
"form": "10-K",
"mapped_tag_share": 0.06451612903225806,
"metrics": {
"cash_and_equivalents": 52645000,
"earnings_per_share_basic": -2.86,
"earnings_per_share_diluted": -2.86,
"net_income": -111483000,
"operating_cash_flow": -87473000,
"operating_income": -125099000,
"shareholders_equity": 484653000,
"shares_outstanding": 47772567,
"total_assets": 512431000,
"total_liabilities": 27778000
},
"metrics_reported": 10,
"period_end": "2025-12-31"
}Source: SEC EDGAR · as of 2026-03-10T00:00:00Z